Man dies after being pulled into MRI machine while wearing metal necklace
The 61-year-old, who has not been named, was pulled by the machine's strong magnetic force after he entered a room at the Nassau Open MRI clinic while a scan was under way, Nassau County Police said.
It is unknown why the man entered the room or if he was a patient at the clinic.
Police added that the accident on Wednesday afternoon "resulted in a medical episode" and left the man in a critical condition in hospital.
He was later pronounced dead.
MRI stands for Magnetic Resonance Imaging. The machines use strong magnetic fields and radio waves to create detailed images of the inside of the body.
Due to the magnetic fields, "very powerful forces" are exerted on objects made of iron, some steels, and other magnetic materials, the National Institute of Biomedical Imaging and Bioengineering says.
It says the forces are "strong enough to fling a wheelchair across the room".
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Mounjaro proves more heart protective than Trulicity in trial of Eli Lilly diabetes drugs
July 31 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling medication for the disease, in reducing the risk of heart attack and stroke in a large, head-to-head study. In the Lilly-funded trial of more than 13,000 patients with type 2 diabetes and high cardiovascular risk, Mounjaro reduced the risk of major adverse heart events by 8% more than Trulicity, the Indianapolis-based drugmaker said. The risk of death from any cause was 16% lower for Mounjaro patients than for those taking Trulicity, though researchers are still studying the data to understand what is behind the difference. Mounjaro is the company's diabetes drug that targets the GLP-1 protein and is also used for weight loss. In the U.S., the obesity version is sold under the brand name Zepbound. Trulicity, which first won U.S. approval in 2014, has been a go-to treatment for preventing heart disease in people with diabetes since the Food and Drug Administration approved it for that use in 2020 following data showing a 12% reduction in heart-related risk. Once Lilly's top seller, Trulicity hit peak sales of $7.4 billion in 2022, aided by the added heart-related approval, according to the company. Mounjaro stole that mantle last year with $11.5 billion in sales, more than double Trulicity's $5.2 billion. Kenneth Custer, president of Lilly's cardiometabolic health division, told Reuters that the new results make Mounjaro an even stronger choice for patients. The new late-stage study, which spanned nearly five years, was the largest and longest trial yet for tirzepatide - the chemical name for Mounjaro - Lilly said. Custer said the company planned to submit its findings to the FDA later this year for an anticipated 2026 expanded approval. The company and Danish rival Novo Nordisk ( opens new tab have been racing for more than two years to prove their competing GLP-1 drugs, already shown to be powerful weight loss agents and diabetes treatments, can also be used to tackle other major diseases and potentially expand insurance coverage. Lilly has a similar study underway testing Zepbound as a treatment for heart disease in obese patients. The FDA approved Novo's rival drug Wegovy to treat heart disease in obese patients in March 2024. Zepbound has already been shown to reduce the risk of hospitalization, death and other adverse outcomes in a smaller study of obese adults with a common type of heart failure, although the FDA has yet to approve the drug for that indication. In diabetes care versus Novo's Ozempic, Mounjaro has captured more than half of the U.S. market share, while Zepbound accounts for just under 60% of its obesity segment in competition with Wegovy, according to IQVIA data shared with Reuters by an analyst. IQVIA did not respond to a request for confirmation. Mounjaro and Trulicity had similar safety profiles, according to the trial results, with most side effects being mild-to-moderate stomach issues that usually resolved after increasing the dose, Lilly said. The GLP-1 drugs are known to cause gastrointestinal issues and more participants stopped taking Mounjaro due to side effects (13.3%) than Trulicity (10.2%).
Metro
an hour ago
- Metro
Never heard of bruxism? You're probably suffering from it
'You've worn your molars right down,' said my dentist, matter-of-factly, as she snapped the latex gloves from her hands. 'I can practically hear your jaw clicking.' I did my best not to feel offended. 'Sorry,' I mumbled, rubbing my aching massester muscles. I'm one of the 8 to 10% of the UK population that grinds their teeth in some way — and I'm betting, you are too. I'm not entirely sure when it started, but these days, I'm all-too-aware that I do it pretty much every night. I've woken myself up one-too-many times by accidentally biting down on my tongue (yes, it really hurts) and when my alarm goes off, I open my eyes with an aching jaw. The habit seeps into my waking hours too. I'll suddenly become aware that my jaw is clenched, as though that's its default position. I once heard (e.g. watched a TikTok video) that the three-finger test is a quick way to asses your jaw mobility. If you can fit three stacked fingers between your upper and lower teeth, you're in the normal range. I can only just about do it. But bruxism, the umbrella term for teeth-grinding or jaw clenching, does more than just make your jaw ache. In fact, it can cause a whole host of issues, from dental problems and headaches, to pain in the face, neck or shoulders, and TMJ disorders. To put it mildly, teeth grinding is no picnic — and it's even more annoying when you consider that you're most likely doing it subconciously. And while the current estimates would suggest that around 6.7 million Brits deal with condition, it seems to be on the rise. Post-pandemic, a USA-based 2021 survey among dentists found that 70% reported an increase in patients grinding and clenching their teeth. More recently, the hashtag #teethgrinding on TikTok has a staggering 262.9 million views, while #unclencyourjaw has 37.7 million. You can even buy tshirts and artwork on Etsy emblazoned with the phrase 'unclench your jaw'. And dentist Dr Sahil Patel, of London's Marylebone Smile Clinic, tells Metro that he's seeing an increasing number of patients displaying signs of bruxism. 'Well developed jaw muscles show as a squarer facial appearance or stronger jawline,' he explains. 'And, on the teeth themselves, bruxism causes accelerated tooth wear and breakage, making teeth look shorter, squarer and yellower. Tooth sensitivity and gum recession can also be a sign.' While it's not always clear why people do it, stress and anxiety is a well-observed cause. 'Our patients are absoloutely more stressed than ever,' Dr Sahil says. 'They may not always disclose it to us, but we can sense when someone is stressed. We're seeing it more with younger people.' Mental Health UK's annual Burnout Report, released in January 2025, found that one in three adults either 'always or often' experience high or extreme levels of pressure or stress, while nine in 10 say they've experienced it at some point over the last year. Mind also found that women are more likely than men to experience common mental health problems (20.7% of women compared to 13.2% of men affected), with young women aged 16 to 24 at the highest risk. It's worth nothing that women are also more likely to experience bruxism, particularly when they're awake. Experts are pretty much in agreement that society is increasinly stressful. Chartered psychologist, Dr Manpreet Dhuffar-Pottiwal says we live an era of 'uncertainty and instability'. She tells Metro: 'Political unrest, economic fluctuations, and environmental crises result in an unpredictability which leaves people feeling out of control regarding their futures.' Our 'always-online' culture, particularly experienced by younger generations also doesn't help, as Dr Manpreet says we face 'technological overload.' 'Social media platforms promote curated representations of life, leading us to measure their worth against others. Additionally, urbanisation has contributed to a disconnection from nature. People confined to busy city lives miss out on the calming effects of the natural world.' Workplace pressures have changed too. 'The rise of remote work and gig economies has introduced ambiguity about job security and increased workloads,' says Dr Manpreet. 'Many young employees, striving for stability in uncertain times, experience burnout and chronic stress as they juggle multiple responsibilities. 'Rigid schedules and the lack of work-life balance lead many to neglect self-care practices.' And finally, as ever, the global pandemic plays a part. Dr Manpreet says: 'It heightened health-related anxieties, with individuals increasingly focused on personal safety. 'This ongoing concern can create a cycle of stress that affects various facets of life. 'It's no surprise that there's a growing prevalence of conditions like bruxism.' So, aside from taking an indefinite holiday to escape the stressors of daily life, what can we do to relieve all this tension? According to Dr Sahil, your dentist can help. 'We can't manage your stress, but we can do a few things to manage the symptoms,' he says. 'Night guards can cushion the contact between the teeth during the night, or reainers, which are thinner, are designed to keep the teeth in their position and protect from night grinding. 'They come in many different forms and materials, but the ballpark cost for these is between £250 and £500.' Alternatively, nurse prescriber and aesthetic trainer, Natalja Andrejeva, says that Botox is an 'emerging go-to solution' for teeth-grinding. 'Over the past few years, I've seen a noticeable rise in clicents seeking relief from bruxism using Botox, especially post-pandemic,' she tells Metro. 'Botox is injected into the masseter muscles to relax them. This reduces the intensity of clenching and grinding without affecting your ability to chew or speak.' More Trending The result? 'Less jaw tension, fewer headaches, and better sleep and quality of life. You'll also get a slightly slimmer jawline,' adds Natalja, founder of Face Code Aesthetic, where she offers the treatment, starting at £290. 'Typically, treatment would be required every three to six months, depending on muscle strength and individual response. 'But over time, some clients find they can space out treatments more as the habit and symptoms lessen.' Of course, the ultimate — and almost impossible solution — is to live a stress-free life. But until then, be safe in the knowledge that you're far from the only one — and don't forget to unclench your jaw. Do you have a story to share? Get in touch by emailing MetroLifestyleTeam@ View More » MORE: 'I never exercised – then I became a naked rambler' MORE: What happens to your body in a heatwave after Tampa hits record-breaking 100 degrees? MORE: GP reveals 7 common mistakes people make when stopping weight loss jabs Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
Daily Mail
an hour ago
- Daily Mail
Trump's health app plan sparks 'selling out' accusations to Big Tech
President Donald Trump is being criticized for a plan that would have Americans share their personal health data with private tech companies. In the East Room on Wednesday, Trump hosted a 'Making Health Technology Great Again' event that unveiled the proposal. The Centers of Medicare & Medicaid Services is securing commitments from top tech companies including Amazon, Apple, Google and OpenAI to start building a 'digital health ecosystem.' The goal would be that Americans could upload their health records to an app that could be easily shared across doctors' offices. 'For decades America's healthcare networks have been overdue for a high tech upgrade - and that's what we're doing,' the president told the crowd. 'The existing systems are often slow, costly and incompatible with one another. But with today's announcement, we take a major step to bring healthcare into the digital age.' Trump said this public-private partnership would move the country away from 'clipboards and fax machines into a new era of convenience, profitability and speed and, frankly, better health for people.' Online, Americans were skeptical of the plan, voicing concern that the president was selling out to 'big tech.' 'More corruption and selling America out to big tech,' one X user posted. Others feared a massive data breach. 'I can see the headlines now, Millions of users have personal health data leaked,' another said. Lawrence Gostin, a Georgetown University law professor who specializes in public health told the Associated Press, 'There are enormous ethical and legal concerns.' 'Patients across America should be very worried that their medical records are going to be used in ways that harm them and their families,' Gostin said. Officials at CMS argued that users would have to opt-in to use these services. Helping sell the plan is Amy Gleason (pictured), an adviser to CMS and the Department of Health and Human Services, who's the acting administrator of the Department of Government Efficiency. Gleason made headlines in March when it was revealed that she, not Elon Musk, was technically in charge of the Trump administration's DOGE efforts, while Musk had a 'special government employee' status. She starred in a CMS promotional video about the effort - and appeared on a panel alongside Trump, CMS Administrator Dr. Mehmet Oz (pictured) and HHS Secretary Robert F. Kennedy Jr. Wednesday afternoon. Gleason spoke about her daughter Morgan who suffers from a rare disease. She recalled how she carried a 'binder of paper records' to every doctor's appointment. 'And I truly believe that if one of those doctors had been able to see her whole history, they would have diagnosed her faster,' Gleason said. She added that if her daughter had access to today's AI tools, a diagnosis may have come quicker as well. 'Today Morgan takes 21 pills a day, gets two infusions a month and has over 40 patient portals,' Gleason said. 'Her disease is very rare, but her experience is very common.' Gleason then asked the audience to envision what healthcare could look like with this big tech-government partnership. 'So Morgan, in six months from now, might show up to her doctor's appointment,' she said. 'Instead of filling out a clipboard with her 21 medications, 12 doctors and her entire medical history, she can just pull out her phone and tap or scan a QR code and seamlessly transfer her digital insurance card, her verified medical record and a digital summary that can help her provider get up to speed faster. We call this "kill the clipboard" as President Trump said,' Gleason said.
